The Global Hospital Acquired Infection Control market size was valued at US$ 29.10 billion in 2022!

The Global Hospital Acquired Infection Control market size was valued at US$ 12.66 billion in 2022 and is predicted to be US$ 16.22 billion by 2030 with a CAGR of 3.2% during the forecast period. What is Driving Hospital Acquired Infection Control?Growing Surgical Procedure The number of surgeries carried out worldwide has increased significantly. According to the National Institute of Health, 310 million major surgeries are performed each year. Due to an increasing elderly population, growing incidence of obesity and other lifestyle disorders, a surge in spinal injuries, and increased sport-related injuries. As a result, there is increasing demand for surgical equipment and devices. Due to the benefits of sterilized items, as well as the increasing knowledge of their efficacy in healthcare settings, this results in increasing demand for the hospital-acquired infection services market.Growing Elderly Population Growing age causes the immune system to deteriorate. Older people are more frequently impacted by chronic illnesses like diabetes, hypertension, chronic obstructive pulmonary disease, and neurovascular diseases. Geriatric populations are more prone to hospital-acquired infection, therefore more focus on the prevention of the infection. As a result, it increases in demand for hospital-acquired infection services.Restraint Factors for Hospital-Acquired Infection Control MarketSide Effects Associated with Disinfectant The majority of chemical disinfectants in the market nowadays have hazardous properties. Sodium hypochlorite, for example, is a potent disinfectant against blood-borne infections. It offers a risk to cleaning and disinfection employees since it is corrosive and an irritant to the respiratory system. Misused disinfectants pose a risk to the environment and patients who come into contact with them. Manufacturers are currently under pressure to develop cleaner, more environmentally friendly disinfectants that are less damaging to people's eyes, like pH-neutral quaternary, butyl-free, and disinfectants based on hydrogen peroxide.Opportunities for Hospital Acquired Infection Control:Growing Emerging Market:The market for infection control is predicted to rise as a result of unexplored potential, enhanced infrastructure for the healthcare sector, an increase in the number of pharmaceutical and medical device companies, and increased consumer demand for infection control products. The healthcare sector is expanding in emerging economies as a result of the rise in demand for more sophisticated manufacturing systems and large government spending to update healthcare infrastructure. Impact of the COVID-19 Pandemic on the Hospital-Acquired Infection Control  Market:The market for hospital-acquired infection management has been significantly impacted by the COVID-19 epidemic. Hospitals are getting overcrowded as a result of the pandemic's devastating effects on healthcare systems around the world. To handle the rising number of cases, temporary hospitals were also set up. The dissemination of COVID-19 has led to an increase in demand for HAI services as a result of the rising number of hospital-acquired infections in hospital settings. The severe COVID-19 effects, such as hospitalization, may, however, aid the hospital-acquired infection control business in gaining traction in the years to come in the wake of the pandemic. What is Hospital Acquired Infection Control?Nosocomial-acquired illnesses that do not exist or incubate at the time of admission to a hospital are known as hospital-acquired infections. These infections include bloodstream infection linked to central lines, urinary tract infection linked to catheters, surgical site infection, pneumonia linked with ventilators, and infection with Clostridium difficile. These infections typically develop after being admitted to the hospital and become apparent 48 hours later. Organizations like the national healthcare safety network of disease control and prevention centers carefully monitor diseases. To stop the hospital-acquired infection and increase patient safety, surveillance is conducted. Increasing surgical procedures, a growing geriatric population, and increasing government initiatives drive market growth.

全球医院获得性感染控制市场规模在2022年达到了126.6亿美元，预计到2030年将达到162.2亿美元，在预测期间内年复合增长率(CAGR)为3.2%。推动医院获得性感染控制发展的因素包括：手术数量的显著增长——全球范围内进行的手术数量显著增加。根据美国国家卫生研究院的数据，每年有3.1亿次重大手术。由于老年人口增加、肥胖及其他生活方式疾病发病率上升、脊椎损伤和与运动相关的伤害增加，对手术设备和器械的需求不断上升。由于灭菌物品的益处以及其在医疗环境中的功效日益为人所知，这导致了医院获得性感染服务市场的需求增长。老年人口的增长——随着年龄的增长，免疫系统会逐渐衰退。老年人更容易受到糖尿病、高血压、慢性阻塞性肺病和神经血管疾病等慢性疾病的困扰。老年人群更易患医院获得性感染，因此对感染的预防更加重视。因此，对医院获得性感染服务的需求不断增加。医院获得性感染控制市场的制约因素——消毒剂相关的副作用——目前市场上的大多数化学消毒剂都具有有害性质。例如，次氯酸钠是一种有效的血源性感染消毒剂。由于其具有腐蚀性和对呼吸系统的刺激性，它对清洁和消毒人员构成风险。误用消毒剂对环境以及接触这些消毒剂的病人构成风险。制造商目前正面临着开发更清洁、更环保、对人的眼睛损害较小的消毒剂的巨大压力，如pH中性的季铵盐、无丁基的消毒剂和基于过氧化氢的消毒剂。医院获得性感染控制市场的机会——新兴市场的增长：由于未开发的潜力、医疗保健行业基础设施的改善、制药和医疗设备公司数量的增加以及消费者对感染控制产品需求的增加，感染控制市场预计将增长。随着对更复杂的制造系统需求的增加以及政府为更新医疗保健基础设施而进行的巨额投资，新兴经济体的医疗保健行业正在扩张。COVID-19大流行对医院获得性感染控制市场的影响：COVID-19大流行对医院获得性感染管理市场产生了重大影响。由于大流行对全球医疗保健系统的毁灭性影响，医院正变得拥挤。为了应对病例数量的增加，还设立了临时医院。COVID-19的传播导致医院环境中医院获得性感染增加，从而增加了对HAI服务的需求。然而，严重的COVID-19影响，如住院，可能会在疫情之后帮助医院获得性感染控制业务获得动力。医院获得性感染控制是什么？在入院时不存在或潜伏的医院获得性疾病被称为医院获得性感染。这些感染包括与中心静脉导管相关的血液感染、与导尿管相关的尿路感染、手术部位感染、与呼吸机相关的肺炎以及艰难梭菌感染。这些感染通常在入院后48小时内发展并显现出来。像疾病控制和预防中心的国家级医疗保健安全网络这样的组织会仔细监测疾病。为了阻止医院获得性感染并提高患者安全，进行监测。手术数量的增加、老年人口的增长以及政府倡议的增加推动了市场增长。